Dipeptiven® is safe in a rat model of moderate liver dysfunction
Summary: Background & aims: Administration of glutamine in patients with liver failure is thought to possibly increase blood ammonia levels, thereby contributing to hepatic encephalopathy. In a rat model of moderate liver dysfunction with elevated plasma glutamine concentrations dose-dependent...
Main Authors: | Melanie K. Bothe, Rosa Abele, Heinrich Topp, Johannes Harleman, Martin Westphal, John F. Stover |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Clinical Nutrition Experimental |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352939318300216 |
Similar Items
-
Dipeptiven® improves kidney pathology in a rat model of chronic kidney disease
by: Melanie K. Bothe, et al.
Published: (2019-06-01) -
Effect of Ritalin on liver histology and some liver enzymes in treptozotocin-safe and diabetic rats
by: Sahar Molzemi, et al.
Published: (2018-05-01) -
The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
by: Rosa Martín-Mateos, et al.
Published: (2021-04-01) -
Increased Oxidative Stress and Mitochondrial Dysfunction in Zucker Diabetic Rat Liver and Brain
by: Haider Raza, et al.
Published: (2015-02-01) -
Erectile dysfunction drugs and oxidative stress in the liver of male rats
by: Salah Sheweita, et al.
Published: (2015-01-01)